Saudi Arabia Patient Monitoring Market Size

Saudi Arabia Patient Monitoring Market Analysis

The Saudi Arabia Patient Monitoring Market size is estimated at USD 222.21 million in 2024, and is expected to reach USD 291.67 million by 2029, growing at a CAGR of 5.59% during the forecast period (2024-2029).

The outbreak of COVID-19 impacted the market, and increased the risk of many diseases such as respiratory diseases, cardiovascular diseases, and other chronic diseases owing to which the demand for patient monitoring devices significantly increased during the initial phases of the pandemic. For instance, according to the NCBI research study published in April 2021, patients infected with COVID-19 were highly prevalent to cardiovascular diseases. The major risk factor associated with these diseases in COVID-19 patients were pneumonia and increased length of stay in the hospital. This study suggested that COVID-19 patients were at higher risk of cardiovascular diseases which propelled the demand for patient monitoring devices. Remote patient monitoring using implantable cardiac devices is a safe alternative to in-person-only visits which led to enhanced patient satisfaction and improved clinical outcomes. Therefore, the demand and use of patient monitoring devices increased drastically during the initial phase of the pandemic. Although, with the declining cases of COVID-19 the demand slightly decreased in the later times of the pandemic. The positive developments and increasing cases of chronic diseases are anticipated to propel the market growth over the forecast period.

The rising incidences of chronic diseases, growth in the geriatric population, and growing preference for home and remote monitoring are the major factors driving the market growth. For instance, as per the research study published in August 2021, the prevalence of dementia in Saudi Arabia was estimated to be around 6.4%. Factors, such as age, low level of education, hypertension, and cardiovascular disease were risk factors for cognitive impairment. Since such disorders require constant monitoring, increasing cases of cognitive impairment and cardiovascular diseases may propel the demand for the product, thereby surging the market growth.

Similarly, according to the NIH research study published in November 2021 the prevalence of coronary artery disease (CAD) symptoms was 25.1%, and the complications associated with the diseases comprised 72.7%. In addition, the same source also reported that the prevalence of a family history of CAD was 9.3%, overweight/obesity was 58.6%, physical inactivity was 79.1%, and smoking was 24.1%. Due to the high prevalence of cardiovascular diseases and their risk factors in the general population, there is a growing need for their diagnosis and treatment, which is likely to fuel market expansion. Thus, owing to such factors significant market growth is anticipated over the forecast period.

However, the high cost of technology is expected to hinder market growth over the forecast period.